Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
92.17
-1.17 (-1.25%)
May 30, 2025, 4:00 PM - Market closed
Zimmer Biomet Holdings Stock Forecast
Stock Price Forecast
According to 20 professional analysts, the 12-month price target for Zimmer Biomet Holdings stock ranges from a low of $95 to a high of $140. The average analyst price target of $113.55 forecasts a 23.20% increase in the stock price over the next year.
Price Target: $113.55 (+23.20%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Zimmer Biomet Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Buy | 5 | 5 | 6 | 6 | 6 | 7 |
| Hold | 12 | 12 | 12 | 12 | 12 | 11 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 21 | 22 | 23 | 23 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $115 → $101 | Hold | Maintains | $115 → $101 | +9.58% | May 12, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $140 → $125 | Buy | Maintains | $140 → $125 | +35.62% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $120 → $104 | Hold | Maintains | $120 → $104 | +12.83% | May 6, 2025 |
| Raymond James | Raymond James | Buy Maintains $119 → $104 | Buy | Maintains | $119 → $104 | +12.83% | May 6, 2025 |
| Stifel | Stifel | Strong Buy Maintains $138 → $115 | Strong Buy | Maintains | $138 → $115 | +24.77% | May 6, 2025 |
Financial Forecast
Revenue This Year
8.26B
from 7.68B
Increased by 7.52%
Revenue Next Year
8.71B
from 8.26B
Increased by 5.55%
EPS This Year
8.06
from 4.43
Increased by 82.02%
EPS Next Year
8.40
from 8.06
Increased by 4.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.6B | 9.2B | 9.7B | ||
| Avg | 8.3B | 8.7B | 9.1B | ||
| Low | 7.8B | 8.2B | 8.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.6% | 11.5% | 11.8% | ||
| Avg | 7.5% | 5.5% | 4.7% | ||
| Low | 1.5% | -1.3% | -1.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.70 | 9.68 | 10.46 | ||
| Avg | 8.06 | 8.40 | 9.26 | ||
| Low | 7.74 | 7.67 | 8.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 96.5% | 20.1% | 24.4% | ||
| Avg | 82.0% | 4.2% | 10.2% | ||
| Low | 74.8% | -4.8% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.